Boston, MA - A new study shows a significant reduction in the incidence of Alzheimer's disease and dementia among subjects taking angiotensin-receptor blockers (ARBs), compared with those taking ACE ...
A long-running dispute as to the supremacy of angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) in the treatment of cardiovascular disease should be put to bed ...
Toronto, ON - A new meta-analysis comparing angiotensin receptor blockers (ARBs) to placebo or ACE inhibitors in heart failure patients "cannot claim that ARBs are superior" to ACE inhibitors in ...
In more than 3 million people worldwide treated for hypertension, ARBs were not only just as effective as ACE inhibitors at reducing the risk of major cardiovascular events, but also associated with a ...
Atrial fibrillation, or AFib, is the most common heart rhythm disorder. With AFib, the beating of the upper chambers of your heart (the atria) becomes irregular, and blood has a harder time reaching ...
kidney Risk of mortality in HF patients with reduced kidney function taking ACE inhibitors and ARBs were evaluated. WASHINGTON, DC—According to data presented at the ACC.17 Scientific Session, ...
Credit: Getty Images. Currently, ACE inhibitors and ARBs are both recommended as first-line therapies for the treatment of hypertension according to US and European guidelines. Angiotensin receptor ...
ACE inhibitors work by interfering with the body's renin-angiotensin-aldosterone system (RAAS). RAAS is a complex system responsible for regulating the body's blood pressure. The kidneys release an ...
In this rapidly evolving setting, clinicians are weighing the alleged harm of continuing these medications in patients for whom ACE inhibitors and ARBs have known benefit against the harm to their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results